EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design of pH/Redox Co-Triggered Degradable Diselenide-Containing Polyprodrug via a Facile One-Pot Two-Step Approach for Tumor-Specific Chemotherapy

Yanru Hu, Peng Liu iD

Molecules · 13.08.2024 · 29 (16) · 3837

DOI: 10.3390/molecules29163837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 13.08.2024. Verfasst von Yanru Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Oxidation-Reduction, Prodrugs, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diselenide bond has attracted intense interest for drug delivery systems (DDSs) for tumor chemotherapy, owing to it possessing higher redox sensitivity than the disulfide one. Various redox-responsive diselenide-containing carriers have been developed for chemotherapeutics delivery. However, the premature drug leakage from these DDSs was significant enough to cause toxic side effects on normal cells. Here, a pH/redox co-triggered degradable polyprodrug was designed as a drug self-delivery system (DSDS) by incorporating drug molecules as structural units in the polymer main chains, using a facile one-pot two-step approach. The proposed PDOX could only degrade and release drugs by breaking both the neighboring acid-labile acylhydrazone and the redox-cleavable diselenide conjugations in the drug’s structural units, triggered by the higher acidity and glutathione (GSH) or reactive oxygen species (ROS) levels in the tumor cells. Therefore, a slow solubility-controlled drug release was achieved for tumor-specific chemotherapy, indicating promising potential as a safe and efficient long-acting DSDS for future tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidation-ReductionProdrugsAntineoplastic AgentsHydrogen-Ion ConcentrationHumansDrug LiberationReactive Oxygen SpeciesDrug Delivery SystemsDrug CarriersCell Line, TumorNeoplasmsPolymersGlutathioneDoxorubicin

Stichwörter der Autor:innen

diselenide bonddrug self-delivery systempH/redox co-triggered degradationpolyprodrugtumor chemotherapy

Substanzen

ProdrugsAntineoplastic AgentsReactive Oxygen SpeciesDrug CarriersPolymersGlutathioneDoxorubicin

Autor:innen und Institutionen

  • State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.

ORCID-Profile: Peng Liu

Zitieren

APA

Hu, Y., & Liu, P. (2024). Design of pH/Redox Co-Triggered Degradable Diselenide-Containing Polyprodrug via a Facile One-Pot Two-Step Approach for Tumor-Specific Chemotherapy. Molecules, 29(16), 3837. https://doi.org/10.3390/molecules29163837

Vancouver

Hu Y, Liu P. Design of pH/Redox Co-Triggered Degradable Diselenide-Containing Polyprodrug via a Facile One-Pot Two-Step Approach for Tumor-Specific Chemotherapy. Molecules. 2024;29(16):3837. doi:10.3390/molecules29163837

BibTeX
@article{Hu2024,
  author = {Hu, Yanru and Liu, Peng},
  title = {Design of pH/Redox Co-Triggered Degradable Diselenide-Containing Polyprodrug via a Facile One-Pot Two-Step Approach for Tumor-Specific Chemotherapy},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {16},
  pages = {3837},
  doi = {10.3390/molecules29163837}
}
Kostenlos starten →